Zhengye Biotechnology Stock (NASDAQ:ZYBT)
Previous Close
$0.68
52W Range
$0.62 - $13.08
50D Avg
$0.86
200D Avg
$1.62
Market Cap
$30.62M
Avg Vol (3M)
$89.10K
Beta
-2.17
Div Yield
-
ZYBT Company Profile
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.